Michele Guida

A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma

Omid Hamid, Henrik Schmidt, Aviram Nissan et al. · Journal of Translational Medicine · 2011 · 531 citations · Full text

Medicine, Immunology, Oncology +17

Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated <i>BRAF</i>-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial

Paolo A. Ascierto, Mario Mandalà, Pier Francesco Ferrucci et al. · Journal of Clinical Oncology · 2022 · 220 citations

Pharmacy, Oncology, Pharmacotherapy +17

Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis

Attila Kollár, Robin L. Jones, Silvia Stacchiotti et al. · Acta Oncologica · 2016 · 188 citations · Full text

Medicine, Oncology, Pharmacology +17

Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study

M. De Lena, Vito Lorusso, Agnese Latorre et al. · European Journal of Cancer · 2001 · 169 citations

Medicine, Oncology, Pharmacology +14

Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort

Paolo A. Ascierto, Ester Simeone, Vanna Chiarion‐Sileni et al. · Journal of Translational Medicine · 2014 · 163 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17